Drug data last refreshed 9h ago · AI intelligence enriched 1w ago
DIAL is a topical antimicrobial solution containing hexachlorophene, a broad-spectrum antibacterial agent approved in 1976. It is used primarily for skin antisepsis and wound cleansing applications. The drug functions as a non-ionic surfactant-based antimicrobial that inhibits bacterial growth on skin surfaces.
With LOE approaching, this mature product likely operates with a lean team focused on generic defense and market maintenance rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Empowering Cardiovascular Health in Custodial Grandparents
Building Relationship, Improving Dialogue, and Growing Empathy (BRIDGE): An Intervention to Support Decision Making for Critically Ill Children
Sixth Generation High-sensitivity Cardiac Troponin T for the Early Rule Out of Myocardial Infarction: a Controlled Before and After Study
Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Worked on DIAL at DIALAB? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on DIAL offers exposure to mature product management, generic competition strategy, and market defense in a stable but declining category. Career growth on this asset is limited; professionals typically use such roles as stepping stones to higher-growth products or to develop expertise in LOE transition management.